Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2026-02-23 @ 5:34 AM
Study NCT ID:
NCT05957757
Status:
RECRUITING
Last Update Posted:
2023-08-31
First Post:
2023-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression
Sponsor:
RenJi Hospital
Organization: